News

Press Release

2026

2025

2024

2023

2022

2021

2020

2019

2018

2017

SynuSight Biotech, an Incubated Company of Mabwell, and ABLi Therapeutics Enter into a License Agreement for [18F]-FD4 to Advance Clinical Research for Parkinson’s Disease